Last reviewed · How we verify
NCT06671184
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
trial testing Observations on clinicopathological factors influencing the difficulty of surgery in Differentiated Thyroid Cancer in 500 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Shanghai 6th People's Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 January 2021 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Observations on clinicopathological factors influencing the difficulty of surgery
Conditions studied
- Differentiated Thyroid Cancer — all drugs for Differentiated Thyroid Cancer →
Sponsor
Shanghai 6th People's Hospital
Who can join
Eligibility, any sex, with Differentiated Thyroid Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
No prior studies have stratified the difficulty of transoral and submental thyroidectomy (TOaST). The investigators aimed to investigate preoperative factors as indicators of difficult TOaSTs and to develop a predictive model accordingly.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Nomogram for predicting difficult transoral and submental thyroidectomy: a retrospective model development and validation study with large-scale population.
Zhan L, Guo B, Tao Z, Deng X, et al · · 2025 · cited 1× · PMID 40216625 · DOI 10.1007/s00464-025-11725-1
Verify or expand the search:
- PubMed search for NCT06671184
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observations on clinicopathological factors influencing the difficulty of surgery
Trials testing the same drug.
- NCT06738888 — Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy · recruiting
Other recruiting trials for Differentiated Thyroid Cancer
Currently open trials in the same condition.
- NCT07436455 — F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer · NA · recruiting
- NCT06458036 — Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) · Phase 2 · recruiting
- NCT05783323 — Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer · Phase 2 · recruiting
- NCT05989425 — Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer · Phase 2 · recruiting
- NCT05599139 — Iodine Uptake After a Low Iodine Diet · NA · recruiting
Other Shanghai 6th People's Hospital trials
Trials by the same sponsor.
- NCT07482891 — An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing · Phase 4 · not yet recruiting
- NCT07414277 — CGM for Insulin-Treated T2DM During Post-Discharge Transition · NA · not yet recruiting
- NCT07359053 — MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma · Phase 2 · recruiting
- NCT07288372 — The CGM-OGTT Glycemic Homeostasis Study · not yet recruiting
- NCT06936657 — Intervention Effects of Optimized Carbohydrate Diet in Patients With Type 2 Diabetes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06671184 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai 6th People's Hospital
- Last refreshed: 28 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06671184.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing